Summary

Report Scope:

This report on the global market for G protein-coupled receptor (GPCR) targeting technologies analyzes the current landscape, including market size and growth trends and segments the market by assay type, product type, application and region. Assay categories include cAMP assays and cGMP assays, calcium functional assays, arrestin functional assays, radioligand binding and GTPgammaS functional assays, reporter gene assays and others. Product types include cell lines, detection kits, cell culture reagents and ligands. Applications include oncology, cardiovascular diseases (CVDs), central nervous system diseases, respiratory diseases and others.

The regions looked at are North America (the U.S., Canada and Mexico), Europe (Germany, the U.K., France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore and Rest of APAC) and the Rest of the World (South America, the Middle East and Africa). The report also includes profiles of leading companies and discusses industry trends, significant products, mergers and acquisitions, and other collaborations or partnerships.

In-text citations are given by the author and the year that the research or study was published. More details on these sources can be found in the table listing them in the Appendix.

Report Includes:

- 22 data tables and 43 additional tables
- An analysis of the global market and technologies for G-protein coupled receptor (GPCR) targeting
- Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the market potential for GPCR targeting technology, industry growth drivers, and forecasts for this market’s segments and sub-segments
- Estimates of the market size and revenue forecast for the global GPCR targeting technology market in USD millions, and a corresponding market share analysis by assay type, product type, application and region
- Discussion of the major market dynamics and shifts, and the regulations, industry challenges and macroeconomic factors affecting the demand for GPCR targeting technology over the coming years
- A look at the recent technological breakthroughs in the use of GPCR targeting technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- Review of the patent filings and research publications for innovations in GPCR targeting technology
- Discussion on the industry’s ESG challenges and practices
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
- Insights into the industry structure for GPCR targeting technology, the competitive landscape, clinical trials and ongoing research activity
- Profiles of the major players in the industry, including Promega Corp., Revvity Inc., Thermo Fisher Scientific Inc., Enzo Biochem Inc., and Danaher Corp.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Types of GPCRs
Introduction of GPCR Cellular Responses
Importance of GPCRs in Disease Physiology
Regulatory Aspect
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Growing Demand for GPCR Drugs
Technological Advances in GPCR Research
Market Restraints
Challenges of Drug Discovery
Limitations of GPCR Structural Studies
Market Opportunities
Personalized Cancer Therapy
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Novel Screening Technology
Structural Analysis in GPCR-Targeted Drug Discovery
Experimental Screening in GPCR-Targeted Drug Discovery
Patent Analysis
Patent Review, by Applicant
Chapter 5 Market Segmentation Analysis
Market Overview
Segmentation Breakdown
GPCR-Targeting: Technologies and Global Markets
Market Analysis by Assay Type
cAMP Assays and cGMP Assays
Calcium Functional Assays
Arrestin Functional Assays
Radioligand-Binding and GTPgammaS Functional Assays
Reporter Gene Assays
Other Assays
Market Analysis by Product Type
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
Market Analysis by Application
Oncology/Cancers
Cardiovascular Diseases
Central Nervous System Diseases
Respiratory Diseases
Other Diseases
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Overview
Ranking of Companies in the Industry
Venture Fundings in the Industry
Chapter 7 Sustainability in the GPCR-Targeting Technologies Industry: An ESG Perspective
Sustainability in the Global GPCR Industry
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
Chapter 8 Appendix
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
DANAHER CORP.
ENZO BIOCHEM INC.
EPICS THERAPEUTICS
EUROFINS SCIENTIFIC
INTERAX BIOTECH AG
MERCK KGAA
ORION BIOTECHNOLOGY CANADA LTD.
PROMEGA CORP.
QIAGEN
REVVITY
TECTONIC THERAPEUTIC
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC